Lindynette 20 (Ethinylestradiol, Gestodene)

Ethinyloestradiol provides estrogenic activity while gestodene supplies progestogenic activity. Together they suppress the hypothalamic‑pituitary‑ovarian axis, preventing the LH and FSH surge needed for ovulation, and they also thicken cervical mucus and alter the endometrium to reduce the chance of implantation.

The dosing regimen for Lindynette 20 is determined by the prescribing healthcare professional. Typically, it involves taking one tablet daily for a defined cycle, often 21 active tablets followed by a 7‑day hormone‑free interval, but the exact schedule should follow the prescriber’s instructions.

Lindynette 20 is not intended for use during pregnancy and should be discontinued if pregnancy occurs. Limited data exist for breastfeeding; while some combined oral contraceptives are considered compatible after the first six weeks postpartum, the decision should be made by a healthcare provider based on individual risk‑benefit assessment.

To order Lindynette 20, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lindynette 20 contains a low‑dose estrogen (20 µg ethinyloestradiol) combined with gestodene, a third‑generation progestogen known for a favorable bleeding profile. Compared with older formulations that use higher estrogen doses or first‑generation progestins, Lindynette 20 may offer reduced estrogen‑related side effects while maintaining contraceptive efficacy.

Store Lindynette 20 at ambient temperature, preferably below 25 °C. Keep the tablets in the original blister pack, protect them from moisture and direct light, and discard any tablets that are discolored or past their expiry date.

Lindynette 20 is taken orally with water, preferably at the same time each day. The tablet should be swallowed whole and not split, chewed, or crushed. Consistency in timing helps maintain stable hormone levels and maximizes contraceptive effectiveness.

The most serious risks include thromboembolic events such as deep‑vein thrombosis, pulmonary embolism, stroke, and myocardial infarction. Hepatic complications like cholestatic jaundice or hepatic adenoma and severe allergic reactions (e.g., anaphylaxis) are also rare but potentially life‑threatening.

Lindynette 20 is contraindicated in women who are pregnant, have known or suspected estrogen‑dependent tumors, have active liver disease, have a history of thromboembolic disorders, are smokers over 35 years of age, or have uncontrolled hypertension. It should also be avoided in individuals with known hypersensitivity to any component of the tablet.